Company

Pathways GI

Rocket Ship Rating

Rocket Ship Rating: 79 out of 100

Maximizing Endoscopic Video Interpretation for Inflammatory Bowel Disease

Also known as PathwaysGI

Health IT
Medical devices & diagnostics
AI native

Status: Operatingas of 2026-09-18
Business model: B2B
Customers: Pharma / CROs, Payors, Providers

pathwaysgi.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Endoscopic Disease Assessment for IBD Patients (using AI/ML)

Funding snapshot

Total raised: $350KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $350K2023-02-17

Funding rounds

Round, 2023: $350K2023-02-17, SEC form D sold, 2 investors